Delphine Vandame | Link Prediction | Best Researcher Award

Ms. Delphine Vandame | Link Prediction | Best Researcher Award

Biocodex | France

Delphine Vandame, PhD, is an accomplished Global Medical Affairs leader with a strong scientific foundation in neuropharmacology and more than 15 years of progressive experience across the pharmaceutical and biotechnology sectors. Driven by a deep passion for science, resilience, and adaptability within the evolving healthcare environment, she currently serves as Global Medical Affairs Head at Biocodex, where she directs worldwide medical strategy for Diacomit in rare pediatric epilepsy, oversees a team of seven Medical Advisors, accelerates digital transformation through AI-driven insight and analytics, and strengthens strategic capabilities across international affiliates. Prior to this, she held key leadership roles at UCB Pharma, including Ecosystem Lead-where she designed and executed immunology strategies for Cimzia and Bimzelx, created a new dermatology business unit, and led a multifunctional medical–commercial team recognized with the 2019 Best MSL Team in EU award-and Medical Manager, guiding EU and French medical strategy across rheumatology and dermatology indications. Earlier roles include Medical Affairs Project Manager at Boehringer Ingelheim, Senior Project Manager at WPP supporting top global pharma organizations, Business Developer at Universal Biotech, Project Manager at CNRS, and Researcher at INSERM and the University of Texas, during which she secured grant funding, contributed to R&D programs, and presented internationally. Dr. Vandame holds a PhD in Neuropharmacology from the Pharmaceutical University of Montpellier, dual Master’s degrees in Biochemistry and Chemistry, and executive leadership training from HEC Paris and Krauthammer; recognized for her work ethic, strategic drive, and leadership excellence, she continues to thrive in fast-paced, cross-functional environments where innovation, scientific rigor, and patient-centric impact intersect.

Profiles: Scopus | Orcid

Featured Publications

"Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis", Delphine Vandame, Epilepsia, 2024.

Nhue Do | Graph Analytics | Best Researcher Award

Dr. Nhue Do | Graph Analytics | Best Researcher Award

Wake Forest University School of Medicine | United States

Author Profile

Scopus

Early Academic Pursuits

Dr. Nhue Do’s academic journey reflects an exceptional blend of medicine, surgery, and leadership. He earned his Doctor of Medicine degree from the University of Southern California, Keck School of Medicine, followed by an MBA from Johns Hopkins University’s Carey Business School, combining medical expertise with management acumen. His early postgraduate training at Harvard Medical School and Beth Israel Deaconess Medical Center exposed him to general surgery, transplantation, and cardiothoracic surgery, setting a strong foundation for a career dedicated to advanced surgical care and innovation.

Professional Endeavors

Dr. Do’s professional career demonstrates an impressive trajectory across leading academic and medical institutions. His appointments span Johns Hopkins University, Vanderbilt University Medical Center, and Advocate Children’s Hospital, where he currently serves as a Congenital Cardiothoracic Surgeon and Surgical Director of the Pediatric Mechanical Circulatory Support Program. His leadership roles, including Associate Vice Chair in Global Surgery at Vanderbilt, showcase his dedication not only to surgical excellence but also to advancing global health initiatives.

Contributions and Research Focus

Throughout his career, Dr. Do has contributed significantly to advancing congenital cardiothoracic surgery and pediatric heart transplantation. He has pioneered clinical protocols such as the use of fresh whole blood, ventricular assist devices, Impella technology, and SherpaPak in pediatric cardiac surgery. His research extends into transplantation, circulatory support devices, and surgical quality improvement. Additionally, his involvement in NIH-funded research and editorial responsibilities highlights his academic commitment to shaping the future of cardiothoracic surgery.

Impact and Influence

Dr. Do’s influence extends beyond the operating room. He has served on advisory boards, national review committees, and editorial boards, ensuring his expertise informs both clinical standards and future research directions. His mentorship in global health programs, leadership in surgical safety councils, and conference organization at national and international levels have amplified his voice in the field of pediatric and congenital heart surgery.

Academic Citations and Recognition

Dr. Do’s scholarly presence is reflected in his active role as a peer reviewer for leading journals such as The Journal of Thoracic and Cardiovascular Surgery and European Journal of Cardio-Thoracic Surgery. His academic honors-including multiple fellowships, scholarships, and leadership programs—underscore his recognition by top medical and surgical bodies worldwide. These achievements reflect his standing as both a clinician and a thought leader in cardiac surgery.

Legacy and Future Contributions

As a board-certified thoracic and congenital heart surgeon with extensive leadership and research experience, Dr. Do is poised to shape the next generation of surgical practice. His ongoing work in pediatric circulatory support and heart transplantation will likely influence future standards of care. Beyond clinical practice, his involvement in mentorship, global health initiatives, and surgical innovation ensures a legacy of advancing both patient outcomes and the broader healthcare landscape.

Conclusion

In summary, Dr. Nhue Do embodies the qualities of an outstanding clinician, educator, and researcher. His career reflects a rare integration of surgical excellence, academic rigor, and global leadership. With his ongoing contributions to congenital cardiothoracic surgery, transplantation, and healthcare innovation, he stands as a role model whose impact will continue to shape the fields of pediatric cardiac surgery and global surgical health for years to come.

Notable Publications

"Forty-eight-hour cold-stored whole blood in paediatric cardiac surgery: Implications for haemostasis and blood donor exposures

  • Author: Kiskaddon AL, Andrews J, Josephson CD, Kuntz MT, Tran D, Jones J, Kartha V, Do NL
  • Journal: Vox Sang
  • Year: 2024